Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 7/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.44 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.44 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 1/20 | 0.44 |
| ▸ | HTR2C | P28335 | 1/20 | 0.44 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.44 |
| ▸ | HRH1 | P35367 | 1/20 | 0.44 |
| ▸ | DRD3 | P35462 | 1/20 | 0.44 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.44 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.44 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 4/20 | 0.41 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.41 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.41 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6413695 | 0.93 | GRIK1 (0.42) | CA2MAPK1CHRM1AKR1A1CHRM3 | |
| SCHEMBL7507487 | 0.91 | CA2 (0.45) | CA2MAPK1CHRM1AKR1A1CHRM3 | |
| SCHEMBL7511769 | 0.91 | CA2 (0.45) | CA2CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL18281636 | 0.91 | CA2 (0.45) | CA2CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL7509833 | 0.91 | CA2 (0.45) | CA2CHRM1AKR1A1CHRM3HTR2A | |
| SCHEMBL11061351 | 0.89 | CHRM1 (0.52) | CA2MAPK1CHRM1AKR1A1CHRM3 | |
| SCHEMBL1649192 | 0.88 | CA2 (0.52) | CA2MAPK1SLC1A2SLC1A1GRIK1 | |
| SCHEMBL7515982 | 0.88 | CA2 (0.52) | CA2MAPK1SLC1A2SLC1A1GRIK1 | |
| SCHEMBL76197 | 0.85 | CA2 (0.48) | CA2MAPK1SLC1A2SLC1A1GRIK1 | |
| SCHEMBL8324703 | 0.85 | CA2 (0.48) | CA2MAPK1SLC1A2SLC1A1GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2620494-B1 | SYNTHESIS OF POLYHYDROXYALKANOATES (PHA) WITH THIOESTER GROUPS IN THE SIDE CHAIN | CONSEJO SUPERIOR DE INVESTIG CIENTÍFICAS (CSIC) (ES) | 2017-02-22 | — | — | EP | disclosed |
| US-20130274510-A1 | SYNTHESIS OF POLYHYDROXYALKANOATES (PHA) WITH THIOESTER GROUPS IN THE SIDE CHAIN | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTÍFICAS (CSIC) (ES) | 2013-10-17 | — | — | US | disclosed |
| EP-2620494-A1 | SYNTHESIS OF POLYHYDROXYALKANOATES (PHA) WITH THIOESTER GROUPS IN THE SIDE CHAIN | Consejo Superior De Investigaciones Científicas (CSIC) (ES) | 2013-07-31 | — | — | EP | disclosed |
| US-6495152-B2 | BIOPOLYMER INCLUDING SULFUR IN THE FORM OF A THIOESTER IN THE POLYMER BACKBONE OR A THIOETHER IN THE POLYMER SIDE CHAINS, PRODUCED BY FERMENTATION OF BACTERIA; USE AS ANTIBACTERIAL COATING, ELECTROLYTE | TEPHA, INC. | 2002-12-17 | — | — | US | disclosed |
| US-20020183502-A1 | Backbone-modified oligonucleotide analogs and methods for using same | MESMAEKER ALAIN DE (CH) | 2002-12-05 | — | — | US | disclosed |
| US-20020106764-A1 | Sulfur containing polyhydroxyalkanoate compositions and method of production | TEPHA, INC. | 2002-08-08 | — | — | US | disclosed |
| WO-2002016627-A2 | SULFUR CONTAINING POLYHYDROXYALKANOATE COMPOSITIONS AND METHOD OF PRODUCTION | TEPHA, INC. (US) | 2002-02-28 | — | — | WO | disclosed |
| WO-1995033731-A1 | HYDROXAMIC ACID DERIVATIVES | F.HOFFMANN-LA ROCHE AG (CH) | 1995-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020183502-A1 | Backbone-modified oligonucleotide analogs and methods for using same | RNGTT, RNASE1, ADAR | CA2 4492/4885MAPK1 4674/4885CHRM1 4884/4885 |
| US-20130274510-A1 | SYNTHESIS OF POLYHYDROXYALKANOATES (PHA) WITH THIOESTER GROUPS IN THE SIDE CHAIN | COASY, FADS1, ABHD5 | CA2 3800/4885MAPK1 3829/4885CHRM1 4106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.